Why the study?
Does polytetrafluoroethylene bicuspid pulmonary valve implantation provide satisfactory early valve function in patients with congenital heart disease?
Population
56 patients with congenital heart disease requiring pulmonary valve replacement, median age 17.5 years.
Design
Cohort
Follow-up
median 15.2 months
Authors
Loading...
Supports early PTFE bicuspid valve function in congenital disease; hypothesis-generating for durability before practice change.
Does polytetrafluoroethylene bicuspid pulmonary valve implantation provide satisfactory early valve function in patients with congenital heart disease?
PTFE bicuspid pulmonary valve implantation demonstrates excellent short-term performance with low pulmonary regurgitation fraction and improved right ventricular volumes.
Lee et al. (2012) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: